Viewing Study NCT05697003


Ignite Creation Date: 2025-12-24 @ 7:48 PM
Ignite Modification Date: 2026-03-11 @ 2:53 PM
Study NCT ID: NCT05697003
Status: UNKNOWN
Last Update Posted: 2023-03-09
First Post: 2023-01-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study for Fluticasone Propionate 100 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Sponsor: Respirent Pharmaceuticals Co Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bioequivalence View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bioequivalence View
None fluticasone propionate View
None salmeterol xinafoate View
None ADVAIR View